You are here
Vertex is committed to support independent, investigator-initiated research designed to advance scientific and medical knowledge about cystic fibrosis. Results of such studies may lead to a better understanding of our therapies, improve patient care, and create new ideas for further disease-related research.
Investigator Initiated Studies
Our Investigator Initiated Study grants support independent, investigator-initiated research designed to advance scientific knowledge of disease states, patient populations and medical treatment, in alignment with our clinical and nonclinical areas of interest. We work with leading researchers, doctors, public health experts and other collaborators who share our vision for transforming the lives of people with serious diseases, their families and society.
Cystic Fibrosis FDA-Approved Compound-Only Requests
We’re interested in supporting cystic fibrosis research to strengthen scientific community knowledge through compound contributions to investigators. Requests through this program will be reviewed for in vitro or ex vivo studies only. Investigators are encouraged to apply to this program by sending their non-confidential research objective, detailed experimental plan and requested material quantity to CompoundRequests@vrtx.com.
Cystic Fibrosis Research Innovation Award (CF RIA)
CF RIA is a program that supports junior investigators in the USA and Canada in the cystic fibrosis field with the goal of advancing our understanding of CF and enhancing patients' lives. Led by a Steering Committee of independent expert clinicians and research scientists, up to five individual research projects are selected annually for awards up to $125,000 (U.S.). Check back in the fall of 2017 for the next call for applications.
Vertex Innovation Awards (VIA)
VIA supports innovative and collaborative clinical research that may improve the care of patients with CF. Applications for clinical research projects are welcomed from across the entire field of CF and are to be led by an individual or individuals with an established career interest in CF. For the 2017 VIA cycle, the independent VIA committee of external experts will select 1-3 projects to support with grants up to a total of €500,000 (Euros).
Circle of Care
Circle of Care is a competitive grant opportunity that funds innovative patient-centric programs for the CF community. Research initiatives considered must focus on one or more of the following categories:
- Help people with CF live a fuller, more engaged lifestyle
- Address the psycho-social challenges patients face
- Improve the overall support of family members of patients
- Support patients in taking more ownership of their healthcare
- Enhance the education of patients, including topics on transition, adherence and navigating new environments.
Now accepting applications through November 30, 2017 for our 2018 program.
Learn more about our 2017 CF Circle of Care grant recipients here.